Non-Hodgkin's Lymphoma - Other Treatments

Proteasome Inhibitors. Bortezomib (Velcade) is a proteasome inhibitor that has been approved for multiple myeloma and is being investigated for NHL. Initial studies are finding some benefits for patients with low-grade and mantle-cell lymphomas.

Cyclin-Dependent Kinase Inhibitors. Flavopiridol, a drug known as a cyclin-dependent kinase inhibitor, is showing some effect in patients with mantle-cell lymphoma. Thisdrug is designed to block enzymes that regulate cell cycles and so help block their growth.

Antibiotics for MALT. Antibiotics may cure or put into complete remission about half of mucosa-associated lymphoid tissue (MALT) cases that are caused by H. pylori infection. Those most likely to respond positively to antibiotics are those in early stages.

Page: 1 | 2 | 3 | 4   previous | next

Email this page  Printer friendly  Bookmark this page